HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease
Author(s)
Vunjak-Novakovic, Gordana V; Bhatia, Sangeeta N; Chen, Christopher; Hirschi, Karen
DownloadPublished version (1.961Mb)
Terms of use
Metadata
Show full item recordAbstract
Our project team is developing an integrated microphysiological platform with functionally connected vascular, liver and cardiac microtissues derived from a single line of human pluripotent stem cells. The platform enables functional representation of human physiology in conjunction with real-time biological readouts (via imaging and homologous reporters for all three cell phenotypes) and compatibility with high-throughput/high-content analysis. In this paper, we summarize progress made over the first year of the grant. Keywords: Vioxx, Glycol Diacrylate, Genotype Pool, Tissue Module, Polyethylene Glycol Diacrylate
Date issued
2013Department
Harvard University--MIT Division of Health Sciences and TechnologyJournal
Stem Cell Research & Therapy
Publisher
Biomed Central Ltd.
Citation
Vunjak-Novakovic, Gordana, et al. “HeLiVa Platform: Integrated Heart-Liver-Vascular Systems for Drug Testing in Human Health and Disease.” Stem Cell Research & Therapy, vol. 4, no. Suppl 1, 2013, p. S8. © 2010 BioMed Central Ltd.
Version: Final published version
ISSN
1757-6512